DTECT-ALL
LIVE

Serial Number

88144649

Owner

DOMAIN THERAPEUTICS

Attorney

Jeffrey M. Goehring

Filing Date

Oct 5, 2018

Add to watchlist:

No watchlists yet
View on USPTO

DTECT-ALL Trademark

Serial Number: 88144649 • Registration: 6010862

DTECT-ALL is a trademark filed by DOMAIN THERAPEUTICS on October 5, 2018. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

DOMAIN THERAPEUTICS (11 trademarks)

850 BOULEVARD SEBASTIEN BRANT, BIOPARC
ILLKIRCH-GRAFFENSTADEN 67400 , FR

Entity Type: 33

Trademark Details

Filing Date

October 5, 2018

Registration Date

March 17, 2020

Published for Opposition

December 31, 2019

Goods & Services

Scientific apparatus and instruments, for the measurement of biological, pharmacological, psychological or chemical phenomena, namely, for measuring interactions between chemicals, molecules, proteins, antibodies and peptides with their targets

Chemical preparations used in the pharmaceutical industries for treating cancer, immune disorders, central nervous system diseases, rare diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases; Chemicals used for biological purposes in the medical field; Chemicals used in the medical and veterinary industries; biological preparations for use in the medical and veterinary industries for the treatment of cancer, immune disorders, central nervous system diseases, rare diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases; biological preparations for use in the pharmaceutical industry for medical treatment of cancer, immune disorders, central nervous system diseases, rare diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases; biological preparations for use in pharmaceuticals industry in the field of industry and science; Pharmaceutical and veterinary pharmaceutical preparations for treating cancer, immune disorders, central nervous system diseases, rare diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical and veterinary use; medical or biological diagnostic tests for diagnosing cancer, immune disorders, central nervous system diseases, rare diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases; medical or biological diagnostic tests for the identification of molecules for treating cancer, immune disorders, central nervous system diseases, rare diseases, inflammatory diseases, metabolic diseases or cardiovascular diseases

Chemical additives used in the biotechnology and pharmaceutical industries; Chemicals used for biotechnology industry; Chemicals used for biological purposes in the field of industry; biological preparations for use in biotechnological industry and science; Chemical reagents, other than for medical or veterinary purpose

Scientific research and development relating to molecules for therapeutic use; scientific research and development relating to new procedures and experiments for discovering, identifying or improving molecules for therapeutic use; scientific laboratory and engineering services for developing molecule for therapeutic use

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Mar 17, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 23, 2022 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 23, 2022 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 23, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 23, 2022 REAP
REGISTERED-PRINCIPAL REGISTER
Mar 17, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 11, 2019 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 27, 2019 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 19, 2019 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 19, 2019 TEME
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Nov 19, 2019 ZZZX
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 21, 2019 CRFA
TEAS POST PUBLICATION AMENDMENT RECEIVED
Aug 21, 2019 EPPA
ELECTRONIC RECORD REVIEW COMPLETE
Apr 23, 2019 FIXD
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Apr 19, 2019 ERRR
ASSIGNED TO LIE
Apr 12, 2019 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Mar 22, 2019 CNSA
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 19, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 19, 2019 GNSL
SUSPENSION LETTER WRITTEN
Mar 19, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 25, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 25, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 25, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 17, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jan 17, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jan 17, 2019 CNRT
ASSIGNED TO EXAMINER
Jan 16, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 16, 2018 NWOS
NEW APPLICATION ENTERED
Oct 9, 2018 NWAP